202 related articles for article (PubMed ID: 30323899)
1. Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines.
Koobotse M; Holly J; Perks C
Oncotarget; 2018 Sep; 9(71):33562-33576. PubMed ID: 30323899
[TBL] [Abstract][Full Text] [Related]
2. Glucose Concentration in Cell Culture Medium Influences the BRCA1-Mediated Regulation of the Lipogenic Action of IGF-I in Breast Cancer Cells.
Koobotse MO; Schmidt D; Holly JMP; Perks CM
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212987
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer.
Brunet J; Vazquez-Martin A; Colomer R; Graña-Suarez B; Martin-Castillo B; Menendez JA
Mol Carcinog; 2008 Feb; 47(2):157-63. PubMed ID: 17620310
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase.
Moreau K; Dizin E; Ray H; Luquain C; Lefai E; Foufelle F; Billaud M; Lenoir GM; Venezia ND
J Biol Chem; 2006 Feb; 281(6):3172-81. PubMed ID: 16326698
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulation of the BRCA1/acetyl-CoA-carboxylase complex.
Ray H; Suau F; Vincent A; Dalla Venezia N
Biochem Biophys Res Commun; 2009 Jan; 378(3):615-9. PubMed ID: 19061860
[TBL] [Abstract][Full Text] [Related]
6. ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.
Ray H; Moreau K; Dizin E; Callebaut I; Venezia ND
J Mol Biol; 2006 Jun; 359(4):973-82. PubMed ID: 16698035
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.
Miralem T; Avraham HK
Mol Cell Biol; 2003 Jan; 23(2):579-93. PubMed ID: 12509456
[TBL] [Abstract][Full Text] [Related]
8. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
Knowlden JM; Gee JM; Barrow D; Robertson JF; Ellis IO; Nicholson RI; Hutcheson IR
Breast Cancer Res; 2011 Sep; 13(5):R93. PubMed ID: 21939528
[TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.
Hosey AM; Gorski JJ; Murray MM; Quinn JE; Chung WY; Stewart GE; James CR; Farragher SM; Mulligan JM; Scott AN; Dervan PA; Johnston PG; Couch FJ; Daly PA; Kay E; McCann A; Mullan PB; Harkin DP
J Natl Cancer Inst; 2007 Nov; 99(22):1683-94. PubMed ID: 18000219
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.
Magnard C; Bachelier R; Vincent A; Jaquinod M; Kieffer S; Lenoir GM; Venezia ND
Oncogene; 2002 Oct; 21(44):6729-39. PubMed ID: 12360400
[TBL] [Abstract][Full Text] [Related]
12. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
Ma J; Yan R; Zu X; Cheng JM; Rao K; Liao DF; Cao D
J Biol Chem; 2008 Feb; 283(6):3418-3423. PubMed ID: 18056116
[TBL] [Abstract][Full Text] [Related]
13. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations.
Maor S; Yosepovich A; Papa MZ; Yarden RI; Mayer D; Friedman E; Werner H
Cancer Lett; 2007 Nov; 257(2):236-43. PubMed ID: 17766039
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1.
Maor S; Papa MZ; Yarden RI; Friedman E; Lerenthal Y; Lee SW; Mayer D; Werner H
Horm Metab Res; 2007 Mar; 39(3):179-85. PubMed ID: 17373631
[TBL] [Abstract][Full Text] [Related]
15. New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines.
Crowe DL; Lee MK
Breast Cancer Res; 2006; 8(1):R1. PubMed ID: 16417649
[TBL] [Abstract][Full Text] [Related]
16. Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.
Cuyàs E; Fernández-Arroyo S; Alarcón T; Lupu R; Joven J; Menendez JA
Oncotarget; 2016 Aug; 7(33):52974-52992. PubMed ID: 27259235
[TBL] [Abstract][Full Text] [Related]
17. miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.
Crippa E; Lusa L; De Cecco L; Marchesi E; Calin GA; Radice P; Manoukian S; Peissel B; Daidone MG; Gariboldi M; Pierotti MA
PLoS One; 2014; 9(1):e87039. PubMed ID: 24475217
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.
Hudelist G; Wagner T; Rosner M; Fink-Retter A; Gschwantler-Kaulich D; Czerwenka K; Kroiss R; Tea M; Pischinger K; Köstler WJ; Attems J; Mueller R; Blaukopf C; Kubista E; Hengstschläger M; Singer CF
Endocr Relat Cancer; 2007 Dec; 14(4):1053-62. PubMed ID: 18045956
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site.
Kang HJ; Yi YW; Kim HJ; Hong YB; Seong YS; Bae I
Cell Death Dis; 2012 Jun; 3(6):e336. PubMed ID: 22739988
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
